Longitudinal distribution of arylamine N-acetyltransferase in the intestine of the hamster, mouse, and rat. Evidence for multiplicity of N-acetyltransferases in the intestine

Biochemical Pharmacology

Volumn 52, Issue 10, 1996, Pages 1613-1620

  Ware, Joseph A ^a   Svensson, Craig K ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

hamsters; intestinal metabolism; N acetyltransferase; p aminobenzoic acid; procainamide; rats, mice

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; ISOENZYME;

ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; HAMSTER; INTESTINE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE;

4-AMINOBENZOIC ACID; ANIMALS; ARYLAMINE N-ACETYLTRANSFERASE; CRICETINAE; ENZYME STABILITY; HEAT; INTESTINES; ISOENZYMES; KINETICS; MESOCRICETUS; MICE; PROCAINAMIDE; RATS; RATS, INBRED F344; RATS, INBRED WKY; SPECIES SPECIFICITY; SUBSTRATE SPECIFICITY; TISSUE DISTRIBUTION;

EID: 0030598397     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00567-9     Document Type: Article

References (50)

1. 1. Schiffman MH and Felton JS, Fried foods and the risk of colon cancer. Am J Epidemiol 131: 376-378, 1990.
2. 2. Gerhardsson De Verdier M, Hagman U, Peters RK, Steineck G and Övervik E, Meat, cooking methods and colorectal cancer: A case-referent study in Stockholm. Int J Cancer 49: 520-525, 1991.
3. 3. Ohgaki H, Takayama S and Sugimura T, Carcinogenicities of heterocyclic amines in cooked food. Mutat Res 259: 399-410, 1991.
4. 4. Sugimura T, Multistep carcinogenesis: A 1992 perspective. Science 258: 603-607, 1992.
5. 5. Kato R, Metabolic activation of mutagenic heterocyclic aromade amines from protein pyrolysates. Crit Rev Toxicol 16: 307-348, 1986.
6. 6. Probst MR, Blum M, Fasshauer I, D'Orazio D, Meyer UA and Wild D, The role of the human acetylation polymorphism in the metabolic activation of the food carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ). Carcinogenesis 13: 1713-1717, 1992.
7. 7. Wild D, Feser W, Michel S, Lord HL and Josephy PD, Metabolic activation of heterocyclic aromatic amines catalyzed by human arylamine N-acetyltransferase isozymes (NAT1 and NAT2) expressed in Salmonella typhimurium. Carcinogenesis 16: 643-648, 1995.
8. 8. Hein DW, Acetylator genotype and arylamine-induced carcinogenesis. Biochim Biophys Acta 948: 37-66, 1988.
9. 9. Lang NP, Chu DZJ, Hunter CF, Kendall DC, Flammang TJ and Kadlubar FF, Role of aromatic amine acetyltransferase in human colorectal cancer. Arch Surg 121: 1259-1261, 1986.
10. 10. Ilett KF, David BM, Detchon P, Castleden WM and Kwa R, Acetylation phenotype in colorectal carcinoma. Cancer Res 47: 1466-1469, 1987.
11. 11. Lang NP, Butler MA, Massengill J, Lawson M, Stotts RC, Hauer-Jensen M and Kadlubar FF, Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. Cancer Epidemiol Biomarkers Prev 3: 675-682, 1994.
12. 12. Wingo PA, Tong T and Bolden S, Cancer statistics, 1995. CA Cancer J Clin 45: 8-30, 1995.
13. 13. Ito N, Hasegawa R, Sano M, Tamano S, Esumi H, Takayama S and Sugimura T, A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis 12: 1503-1506, 1991.
14. 14. Schut HAJ and Herzog CR, Formation of DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in male Fischer 344 rats. Cancer Lett 67: 117-124, 1992.
15. 15. Feng Y, Wagner RJ, Fretland AJ, Becker WK, Cooley AM, Pretlow TP, Lee KJ and Hein DW, Acetylator genotype (NAT2)-dependent formation of aberrant crypts in congenic Syrian hamsters administered 3,2′-dimethyl-4-amino-biphenyl. Cancer Res 56: 527-531, 1996.
16. 16. Miller EC and Miller JA, Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules. Cancer 47: 2327-2345, 1981.
17. 17. Umemoto A, Kajikawa A, Tanaka M, Hamada K, Seraj MJ, Kubota A, Nakayama M, Kinouchi T, Ohnishi Y, Yamashita K and Monden Y, Presence of mucosa-specific DNA adduct in human colon: Possible implication for colorectal cancer. Carcinogenesis 15: 901-905, 1994.
18. 18. Hamada K, Umemoto A, Kajikawa A, Tanaka M, Seraj MJ, Nakayama M, Kubota A and Monden Y, Mucosa-specific DNA adducts in human small intestine: A comparison with the colon. Carcinogenesis 15: 2677-2680, 1994.
19. 19. Kajikawa A, Umemoto A, Hamada K, Tanaka M, Kinouchi T, Ohnishi Y and Monden Y, Mucosa-preferential DNA adduct formation by 2-amino-3-methylimidazo[4,5-f]quinoline in the rat colonic wall. Cancer Res 55: 2769-2773, 1995.
20. 20. Jenne JW, Partial purification and properties of the isoniazid transacetylase in human liver. Its relationship to the acetylation of p-aminosalicylic acid. J Clin Invest 44: 1992-2002, 1965.
21. 21. Pacifici GM, Franchi M, Gervasi PG, Longo V, di Simplicio P, Temellini A and Giuliani L, Profile of drug-metabolizing enzymes in human ileum and colon. Pharmacology 38: 137-145, 1989.
22. 22. Ilett KF, Ingram DM, Carpenter DS, Teitel CH, Lang NP, Kadlubar FF and Minchen RF, Expression of monomorphic and polymorphic N-acetyltransferases in human colon. Biochem Pharmacol 47: 914-917, 1994.
23. 23. Hearse DJ and Weber WW, Multiple N-acetyltransferases and drug metabolism: Tissue distribution, characterization, and significance of mammalian N-acetyltransferase. Biochem J 132: 519-526, 1973.
24. 24. Ilett KF, Reeves PT, Minchin RF, Kinnear BF, Watson HF and Kadlubar FF, Distribution of acetyltransferase activities in the intestines of rapid and slow acetylator rabbits. Carcinogenesis 12: 1465-1469, 1991.
25. s slow acetylator congenic mice. Drug Metab Dispos 21: 1057-1063, 1993.
26. 26. Land SJ, Jones RF and King CM, Biochemical and genetic analysis of two acetyltransferases from hamster tissues that can metabolize aromatic amine derivatives. Carcinogenesis 15: 1585-1595, 1994.
27. 27. Ogolla F, Ferguson RJ, Kirlin WG, Trinidad A, Andrews AF, Mpezo M and Hein DW, Acetylator genotype-dependent expression of arylamine N-acetyltransferase and N-hydroxyarylamine O-acetyltransferase in Syrian inbred hamster intestine and colon identity with hepatic acetylation polymorphism. Drug Metab Dispos 18: 680-685, 1990.
28. 28. Smith TJ and Hanna PE, N-Acetyltransferase multiplicity and the bioactivation of N-arylhydroxyamic acids by hamster hepatic and intestinal enzymes. Cancer Res 7: 697-702, 1986.
29. 29. Doll MA and Hein DW, Cloning, sequencing and expression of NAT1 and NAT2 encoding genes from rapid and slow acetylator inbred rats. Pharmacogenetics 5: 247-251, 1995.
30. 30. Hein DW, Rustan TD, Bucher KD, Furman EJ and Martin WJ, Extrahepatic expression of the N-acetylation polymorphism toward arylamine carcinogens in tumor target organs of an inbred rat model. J Pharmacol Exp Ther 258: 232-236, 1991.
31. 31. Wick MJ, Yeh HM and Hanna PE, An isozyme-selective affinity label for rat hepatic acetyltransferases. Biochem Pharmacol 40: 1389-1398, 1990.
32. 2-receptor antagonists on rat liver cytosolic acetyl CoA:arylamine N-acetyltransferase activity. Drug Metab Dispos 20: 74-78, 1992.
33. 33. Bradford MM, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
34. 34. Hein DW, Doll MA, Gray K, Rustan TD and Ferguson RJ, Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus. Cancer Res 53: 509-514, 1993.
35. 35. Wick MJ and Hanna PE, Bioactivation of N-arylhydroxamic acids by rat hepatic N-acetyltransferase: Detection of multiple enzyme forms by mechanism-based inactivation. Biochem Pharmacol 39: 991-1003, 1990.
36. 36. Hein DW, Kirlin WG, Ferguson RF and Weber WW, Biochemical investigation of the basis for the genetic N-acetylation polymorphism in the inbred hamster. J Pharmacol Exp Ther 234: 358-364, 1985.
37. 37. Cribb AE, Nakamura H, Grant DM, Miller MA and Spielberg SP, Role of polymorphic and monomorphic human arylamine N-acetyltransferases in determining sulfamethoxazole metabolism. Biochem Pharmacol 45: 1277-1282, 1993.
38. 38. Andres HH, Klem AJ, Szabo SM and Weber WW, New spectrophotometric and radiochemical assays for acetyl-coA: arylamine N-acetyltransferase applicable to a variety of arylamines. Anal Biochem 145: 367-375, 1985.
39. 39. Drobitch RK, Tomilo M and Svensson CK, Immunomodulation and drug acetylation: Influence of the immunomodulator tilorone on hepatic, renal and blood N-acetyltransferase activity and on hepatic cytosolic acetyl coenzyme A content. Biochem Pharmacol 43: 1643-1648, 1992.
40. 40. Hein DW, Rustan TD, Bucher KD, Martin WJ and Furman EJ, Acetylator phenotype-dependent and -independent expression of arylamine N-acetyltransferase isozymes in rapid and slow acetylator inbred rat liver. Drug Metab Dispos 19: 933-937, 1991.
41. 41. Juberg DR, Bond JT and Weber WW, N-Acetylation of aromatic amines: Genetic polymorphism in inbred rat strains. Pharmacogenetics 1: 50-57, 1991.
42. 42. Gillette JR, A perspective on the role of chemically reactive metabolites of foreign compounds in toxicity-I. Correlation of changes in covalent binding of reactivity metabolites with changes in the incidence and severity of toxicity. Biochem Pharmacol 23: 2785-2794, 1974.
43. 43. Kaderlik KR, Minchen RF, Mulder GJ, Ilett KF, Daugaard-Jenson M, Teitel CH and Kadlubar FF, Metabolic activation pathway for the formation of DNA adducts of the carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rat extrahepatic tissues. Carcinogenesis 15: 1703-1709, 1994.
44. 44. Glowinski IB and Weber WW, Genetic regulation of aromatic amine N-acetylation in inbred mice. J Biol Chem 257: 1424-1430, 1982.
45. 45. Land SJ, Characterization of Rat Hepatic Acetyltransferase. Ph.D. Dissertation, Wayne State University Detroit, MI, 1993.
46. 46. Grant DM, Blum M, Beer M and Meyer UA, Monomorphic and polymorphic human arylamine N-acetyltransferases: A comparison of liver isozymes and expressed products of two cloned genes. Mol Pharmacol 39: 184-191, 1991.
47. 47. Hein DW, Hirata M, Glowinski IB and Weber WW, Biochemical evidence for the coexistence of monomorphic and polymorphic N-acetyltransferase activities on a common protein in rabbit liver. J Pharmacol Exp Ther 220: 1-7, 1982.
48. 48. Wick MJ and Hanna PE, Inactivation of hamster monomorphic N-acetyltransferase by vinyl fluorenyl ketone. Biochem Pharmacol 48: 1835-1838, 1994.
49. 49. Lin D, Meyer DJ, Ketterer B, Lang NP and Kadlubar FF, Effects of human and rat glutathione S-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: A possible mechanism of organ specificity in their carcinogenesis. Cancer Res 54: 4920-4926, 1994.
50. 50. Westra JG, Flammang TJ, Fullerton NF, Beland FA, Weis CC and Kadlubar FF, Formation of DNA adducts in vivo in rat liver and intestinal epithelium after administration of the carcinogen 3,2′-dimethyl-4-aminobiphenyl and its hydroxamic acid. Carcinogenesis 6: 37-44, 1985.